Cantor Fitzgerald, L. P. Tiziana Life Sciences LTD Transaction History

Cantor Fitzgerald, L. P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.67 - $1.18 $402 - $708	-600 Reduced 4.96%	11,491 $7,000
Q4 2023 Feb 14, 2024	BUY	$0.55 - $0.85 $6,650 - $10,277	12,091 New	12,091 $6,000
Q1 2023 May 15, 2023	SELL	$0.51 - $1.1 $10,455 - $22,550	-20,500 Reduced 44.57%	25,491 $27,000
Q3 2022 Nov 14, 2022	BUY	$0.55 - $0.83 $25,295 - $38,172	45,991 New	45,991 $36,000

4.64M

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $196M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.